Issue
Med Sci (Paris)
Volume 40, Number 2, Février 2024
Nos jeunes pousses ont du talent !
Page(s) 209 - 211
Section Partenariat médecine/sciences - Écoles doctorales - Masters
DOI https://doi.org/10.1051/medsci/2023213
Published online 27 February 2024
  1. Williams N, Lee J, Mitchell E, et al. Life histories of myeloproliferative neoplasms inferred from phylogenies. Nature 2022; 602 : 162–8 [CrossRef] [PubMed] [Google Scholar]
  2. Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 2016 ; 127 : 2 391–405. [Google Scholar]
  3. Vainchenker W, Kralovics R. Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms. Blood 2017 ; 129 : 667–679. [CrossRef] [PubMed] [Google Scholar]
  4. Van Egeren D, Escabi J, Nguyen M, et al. Reconstructing the Lineage Histories and Differentiation Trajectories of Individual Cancer Cells in Myeloproliferative Neoplasms. Cell Stem Cell 2021; 28 : 514–523.e9. [CrossRef] [PubMed] [Google Scholar]
  5. Hermange G, Rakotonirainy A, Bentriou M, et al. Inferring the initiation and development of myeloproliferative neoplasms. Proc Natl Acad Sci U S A 2022; 119 : e2120374119. [CrossRef] [PubMed] [Google Scholar]
  6. Hirsch P, Mamez AC, Belhocine R, et al. Clonal history of a cord blood donor cell leukemia with prenatal somatic JAK2 V617F mutation. Leukemia 2016 ; 30 : 1 756–759. [Google Scholar]
  7. Watson CJ, Papula AL, Poon GYP, et al. The evolutionary dynamics and fitness landscape of clonal hematopoiesis. Science 2020; 367 : 1449–54. [CrossRef] [PubMed] [Google Scholar]
  8. Mosca M, Hermange G, Tisserand A, et al. Inferring the dynamics of mutated hematopoietic stem and progenitor cells induced by IFNα in myeloproliferative neoplasms. Blood 2021; 138 : 2 231–43. [Google Scholar]
  9. Gisslinger H, Klade C, Georgiev P, et al. Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV) : a randomised, non-inferiority, phase 3 trial and its extension study. Lancet Haematol 2020; 7 : e196–208. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.